.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Farmers Insurance
Johnson and Johnson
Julphar
McKinsey
Colorcon
Federal Trade Commission
Merck
Teva

Generated: December 12, 2017

DrugPatentWatch Database Preview

Organon Usa Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?

ORGANON USA INC has thirty-three approved drugs.

There are eight US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.

There are one hundred and seventy-eight patent family members on ORGANON USA INC drugs in forty countries and thirty-five supplementary protection certificates in eleven countries.

Summary for Organon Usa Inc

International Patents:178
US Patents:8
Tradenames:34
Ingredients:29
NDAs:33
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Organon Usa IncFOLLISTIM AQfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021211-003Feb 11, 2004DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Organon Usa IncIMPLANONetonogestrelIMPLANT;IMPLANTATION021529-001Jul 17, 2006DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Organon Usa IncLIQUAEMIN LOCK FLUSHheparin sodiumINJECTABLE;INJECTION000552-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncZEMURONrocuronium bromideINJECTABLE;INJECTION020214-002Mar 17, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncREMERON SOLTABmirtazapineTABLET, ORALLY DISINTEGRATING;ORAL021208-001Jan 12, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncFOLLISTIM AQfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021211-003Feb 11, 2004DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Organon Usa IncNORCURONvecuronium bromideINJECTABLE;INJECTION018776-002Apr 30, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncCALDEROLcalcifediolCAPSULE;ORAL018312-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncLIQUAMARphenprocoumonTABLET;ORAL011228-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncSUCCINYLCHOLINE CHLORIDEsuccinylcholine chlorideINJECTABLE;INJECTION080997-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Organon Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa IncRAPLONrapacuronium bromideINJECTABLE;INJECTION020984-001Aug 18, 1999► Subscribe► Subscribe
Organon Usa IncPAVULONpancuronium bromideINJECTABLE;INJECTION017015-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Organon Usa IncREMERONmirtazapineTABLET;ORAL020415-002Jun 14, 1996► Subscribe► Subscribe
Organon Usa IncGANIRELIX ACETATEganirelix acetateINJECTABLE;INJECTION021057-001Jul 29, 1999► Subscribe► Subscribe
Organon Usa IncZEMURONrocuronium bromideINJECTABLE;INJECTION020214-001Mar 17, 1994► Subscribe► Subscribe
Organon Usa IncPAVULONpancuronium bromideINJECTABLE;INJECTION017015-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Organon Usa IncNORCURONvecuronium bromideINJECTABLE;INJECTION018776-002Apr 30, 1984► Subscribe► Subscribe
Organon Usa IncCALDEROLcalcifediolCAPSULE;ORAL018312-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Organon Usa IncFOLLISTIM AQfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021273-002Aug 26, 2005► Subscribe► Subscribe
Organon Usa IncZEMURONrocuronium bromideINJECTABLE;INJECTION020214-003Mar 17, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ORGANON USA INC drugs

Drugname Dosage Strength Tradename Submissiondate
ethinyl estradiol and etonogestrelVaginal Ring0.015 mg/24 hour and 0.12 mg/24 hourNUVARING6/17/2013
ganirelix acetateInjection250 mcg/0.5 mL, 1 mL PFSGANIRELIX ACETATE3/30/2012

International Patent Family for Organon Usa Inc Drugs

Country Document Number Estimated Expiration
Norway320394► Subscribe
Portugal974359► Subscribe
Russian Federation2007132007► Subscribe
Norway20073749► Subscribe
Poland190103► Subscribe
Hong Kong1026615► Subscribe
South Africa200705955► Subscribe
Russian Federation2206325► Subscribe
TaiwanI434676► Subscribe
Japan4876077► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Organon Usa Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0038Belgium► SubscribePRODUCT NAME: ROCURONIUMBROMIDE; NAT. REGISTRATION NO/DATE: 63 IS 9 F 12 19960709; FIRST REGISTRATION: NL RVG 16946 19940406
2006 00038Denmark► SubscribePRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
49/2008Austria► SubscribePRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON
C/GB00/024United Kingdom► SubscribePRODUCT NAME: GANIRELIX OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/130/001 20000517; UK EU/1/00/130/002 20000517
156Luxembourg► SubscribePRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
9C0041Belgium► SubscribePRODUCT NAME: ETONOGESTREL; NATL. REGISTRATION NO/DATE: 52 IS 296 F 14 19990531; FIRST REGISTRATION: NL RVG 21168 19980825
2016 00016Denmark► SubscribePRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
00C/030Belgium► SubscribePRODUCT NAME: GANIRELIX; REGISTRATION NO/DATE: EU/1/00/130/001 20000518
0814Netherlands► SubscribePRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
6/2010Austria► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Express Scripts
Moodys
Cipla
US Army
Cerilliant
Mallinckrodt
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot